Lichen Secondary Metabolites As Potential Antibiotic Agents: 3.1 Needing For New Antibiotics From Nature
Lichen Secondary Metabolites As Potential Antibiotic Agents: 3.1 Needing For New Antibiotics From Nature
Lichen Secondary Metabolites As Potential Antibiotic Agents: 3.1 Needing For New Antibiotics From Nature
Abstract It is well known that pathogenic microbes pose serious threats to human
health and are increasing in prevalence in institutional health-care settings due to
the growing resistance that infectious agents have developed against antibiotics.
Therefore, new alternatives for combating the spread of infection through
antibiotic-resistant microbes are necessary for keeping pace with the evolution of
“super” pathogens. Natural products are proposed as a therapeutic alternative to
conventional antimicrobial treatment. Among them, lichen-derived product and
their antibiotic properties are of special interest to scientists as up to 50 % of all
lichens have been reported to possess antibiotic activities. A great number of
reports concerning the antimicrobial screening of lichens have appeared in the
literature. According to published data, the lichens and their secondary metabolites
exhibited the activity against a great number of microorganisms. Therefore, the
present study represents lichens as very interesting source of bioactive compounds
which provide unlimited opportunities for new antimicrobial agents.
Before the introduction of antibiotics in the 1940s, infections were rare, but rapidly
increased in frequency as the use of antibiotics increased. In fact, most antibiotics
that were first used in the 1940s and 1950s are no longer used clinically because
nowadays the resistance of infectious beings to these antibiotics is very common.
Over time they have been developing new antibiotics, and with the introduction of
each, new drug-resistant bacteria appeared rapidly. The process of resistance is
augmented by short generation times of bacteria enabling rapid mutation and
selection of resistant strains and a horizontal transfer of resistance genes. Bacterial
pathogens resistant to more than one, or even most clinically used antibiotics, have
become common. Today, we moved the mode of use and prescription of antibiotics
in order to try to slow the relentless pace of bacterial evolution but not yet found a
solution to this problem. Microbiologists continue to study how bacteria evolve so
that we can predict how they will respond to medical treatment and so we can better
manage the evolution of infectious diseases.
Bacteria are able to resist the effects of antimicrobials through preventing
intracellular access, immediately removing antimicrobial substances through efflux
pumps, modifying the antimicrobial agent through enzymatic breakdown, or modi-
fying the antimicrobial targets within the bacterial cell to render the substance
ineffective. Successful development of resistance often results from a combination
of two or more of these strategies (Sheldon 2005).
The first antibiotic resistance mechanism described was that of penicillinase. Its
presence and activity were first reported by Abraham and Chain in 1940 shortly
after its discovery (Abraham and Chain 1940).
Antimicrobial resistance traits are genetically coded and can either be intrinsic
or acquired. Intrinsic resistance is due to innately coded genes which create natural
“insensitivity” to a particular antibiotic. Innate resistance is normally expressed by
virtually all strains of that particular bacterial species. Acquired resistance is gained
by previously susceptible bacteria either through mutation or horizontally obtained
from other bacteria possessing such resistance via transformation, transduction, or
conjugation. Acquired resistance is limited to subpopulations of a particular bacte-
rial species and may result from selective pressure exerted by antibiotic usage.
The drug resistance of human and animal pathogens is one of the best
documented in biological evolution and a serious problem in both developed and
developing countries. The consumption of more than one ton daily antibiotics in
some European countries has resulted in resistance to bacterial populations, thus
causing a serious public health problem. In view of this scenario, the search for new
antimicrobial substances from natural sources, including lichens, has gained impor-
tance in pharmaceutical companies.
Since lichens produce a variety of substances with antimicrobial properties, it is
expected that screening programs discover candidate compounds for the develop-
ment of new antibiotics. However, scientific research to determine the therapeutic
potential of lichens is limited, and there is a lack of scientific studies that confirm
the possible experimental antibiotic properties of a large number of lichens. It is
expected that compounds that reach targets different from those used by known
antibiotics may be active against resistant pathogens.
triphosphate (Abo-Khatwa et al. 1996; Bouaid and Vicente 1998). The ability of
usnic acid to shuttle protons through the membranes was confirmed by studies with
artificial phospholipid membranes (Bačkor et al. 1998). A model for the function of
usnic acid in the control of the intracellular pH of lichens was recently proposed
(Hauck and Jurgens 2008) that involves two hypotheses: (1) at the optimum pH near
the pKa1 value of usnic acid (4, 4), buffering is assumed to be compensated by the
usnic acid-mediated proton transport into the cell and (2) at low pH (<3.5), the
equilibrium between usnic acid and usneate shifts toward the usnic acid, and
protons are increasingly shuttled into the cells, considering that usnic acid dissoci-
ates to usneate at cytosolic pH 7.4. This implies that more protonated molecules
would be able to cross the membrane and release protons into the cell. As a result,
the intracellular pH would decrease and lead to the death of the cells (Hauck and
Jurgens 2008).
In addition, Macia˛g-Dorszyńska et al. (2014) assume that inhibition of RNA
synthesis may be a general mechanism of antibacterial action of usnic acid, with
additional direct mechanisms, such as impairment of DNA replication in B. subtilis
and S. aureus.
Usnic acid has been used as antibiotic (e.g., Binan, Usno) and is still available as
a topical antiseptic in some products (e.g., Gessato shaving treatment from Italy and
Camillen 60 Fudes spray and nail oil from Germany). It is suggested for application
in medical devices, since usnic acid inhibits bacterial biofilm formation on polymer
surfaces (Francolini et al. 2004). This compound or derivatives are valuable active
compounds against serious pathogens such as vancomycin-resistant enterococci,
methicillin-resistant Staphylococcus aureus (Elo et al. 2007), mycobacteria
(Ingolfsdottir et al. 1998), or Listeria monocytogenes (Tomasi et al. 2006).
Phenols Most lichen substances with antibiotic activity are phenolic metabolites.
Phenols are one of the largest classes of secondary biomolecules, which are
characterized by the presence of aromatic rings with hydroxyl group bonded
directly to an aromatic hydrocarbon group. Although they are firstly identified in
plants (Cowan 1999), their presence was also observed in lichens (Odabasoglu
et al. 2004; Kekuda et al. 2011; Ranković et al. 2010, 2014; Mitrović et al. 2011;
Kosanić and Ranković 2011; Manojlović et al. 2012). In recent years, there was a
causal relationship between the total contents of these compounds with biological
activities recorded in a large number of lichens, which include anti-inflammatory,
antiallergic, anticancer, antihypertensive, antirheumatic, and antibacterial activity.
Antimicrobial properties of phenolics are explained by the presence of phenol
hydroxyl groups, the number of which is in correlation with their toxicity toward
microorganisms (Cowan 1999). The possible mechanisms of their action include
inhibition of extracellular microbial enzymes, deprivation of the substrates required
for microbial growth, or direct action on microbial metabolism through inhibition
of oxidative phosphorylation, by sulfhydryl groups and some nonspecific inter-
actions (Cowan 1999).
3 Lichen Secondary Metabolites as Potential Antibiotic Agents 85
Fig. 3.1 Disk diffusion (a), agar dilution (b), and broth microdilution (c) methods to measure the
in vitro antimicrobial activity of test samples
The screening of lichen extracts has been of great interest to scientists for the
discovery of new compound effective in the treatment of microbial infection. There
are various reports on the antimicrobial activity of crude lichen extracts.
The first study on the antibiotic properties of lichens was carried out by
Burkholder et al. (1944). He tested 42 lichens for antibiotic property and 27 were
reported to inhibit growth of bacteria. A number of lichen extracts were screened
for antibacterial activity in the 1950s, and in many cases activity was confirmed
against mycobacteria and Gram-positive organisms (Stoll et al. 1950). A review of
the work performed during this period is presented in Vartia (1973). More recent
reports include a study describing the antimicrobial screening of lichen extracts and
subsequent isolation of compounds with a broad spectrum of activity against
filamentous fungi, yeast, as well as Gram-positive and Gram-negative bacteria.
Extracts of Andean lichens Protousnea poeppigii and Usnea florida demon-
strated antimicrobial activity against the pathogenic fungi Microsporum gypseum,
Trichophyton mentagrophytes, and T. rubrum. Gram-positive Staphylococcus
aureus and Bacillus subtilis were sensitive to methanolic extracts of four different
3 Lichen Secondary Metabolites as Potential Antibiotic Agents 89
Antarctic lichen species (Paudel et al. 2008). Ranković et al. (2007a, b) tested
aqueous, acetone, and methanol extracts of Cladonia furcata, Parmelia caperata,
Parmelia pertusa, Hypogymnia physodes, Umbilicaria polyphylla, Lasallia
pustulata, Parmelia sulcata, Umbilicaria crustulosa, and Umbilicaria cylindrica
from Serbia on six species of bacteria and ten species of fungi. The strongest
activity was observed with methanol extracts of Parmelia pertusa and Parmelia
sulcata, and the weakest activity was manifested by Parmelia caperata and
Umbilicaria cylindrica. Aqueous extracts of all tested lichen species were inactive.
Bacillus mycoides was the most sensitive bacterial species tested, whereas Candida
albicans was the most sensitive fungal species examined. Other studies monitored
Ramalina farinacea and 69 species of lichens from New Zealand and showed their
inhibitory effect against a lot of bacteria such as Bacillus, Pseudomonas, E. coli,
Streptococcus, Staphylococcus, Enterococcus, and Mycobacterium (Esimone and
Adikwn 1999; Perry et al. 1999). Behera et al. (2005) reported that acetone,
methanol, and light petroleum extracts of lichen Usnea ghattensis were effective
against Bacillus licheniformis, B. megaterium, B. subtilis, and S. aureus. Also,
Karagoz et al. (2009) evaluated aqueous and ethanol extracts of 11 different species
from Turkey and determined potent antibacterial activity of aqueous extract of
Peltigera polydactyla and ethanol extract of Ramalina farinacea. Recently,
Mitrović et al. (2011) studied antibacterial and antifungal activity of methanol
extracts of five lichen species (Parmelia sulcata, Flavoparmelia caperata, Evernia
prunastri, Hypogymnia physodes, and Cladonia foliacea). The analysis of their
antibacterial potential was performed on 15 strains of bacteria and revealed the
strongest inhibitory effect, especially on Gram-positive bacteria, of Hypogymnia
physodes and Cladonia foliacea. In the case of fungi, Evernia prunastri exerted the
best effect on yeasts, while Hypogymnia physodes were better on filamentous fungi.
Similarly, acetone extracts of the lichens Cladonia furcata, Lecanora atra, and
Lecanora muralis were studied for their antimicrobial potential (Ranković
et al. 2011). The antimicrobial activity was estimated by determination of the
minimal inhibitory concentration by the broth microdilution method against six
species of bacteria and ten species of fungi. The extract of Cladonia furcata was the
most active antimicrobial agent with minimum inhibitory concentration values
ranging from 0.78 to 25 mg/ml, while the lowest activity was shown by Lecanora
muralis. In similar research, antifungal activity of hexane, ethyl acetate, and
methanol extracts of Parmelia reticulata was evaluated against soilborne patho-
genic fungi, namely, Sclerotium rolfsii, Rhizoctonia solani, R. bataticola, Fusarium
udum, Pythium aphanidermatum, and P. debaryanum by Goel et al. (2011). Maxi-
mum antifungal activity was exhibited by hexane and ethyl acetate extracts against
most of the test pathogens.
Acetone, diethyl ether, and ethanol extracts of the lichen Cetraria aculeata for
their antimicrobial activity have been evaluated. The extracts were found active
against Escherichia coli, Staphylococcus aureus, Aeromonas hydrophila, Proteus
vulgaris, Streptococcus faecalis, Bacillus cereus, Bacillus subtilis, Pseudomonas
aeruginosa, and Listeria monocytogenes. However, no antimicrobial activity
against the fungi was detected (Türk et al. 2003). The lichen extract almost
90 M. Kosanić and B. Ranković
increased by twofold in the presence of the stock solution of the colloidal silver
concentrate. The ointment containing the extract of lichen Ramalina farinacea
exhibited antimicrobial activities against Escherichia coli, Salmonella typhi, Asper-
gillus niger, and Candida albicans (Ofokansi and Esimone 2005).
The aqueous and ethanol extracts prepared from some lichens species were
evaluated for antibacterial activity against six standard strains (Escherichia coli,
Pseudomonas aeruginosa, Bacillus subtilis, Klebsiella pneumoniae, Staphylo-
coccus aureus, and Staphylococcus epidermidis) and (Aeromonas) that were iso-
lated from different lakes. The aqueous and ethanol extracts showed a variable
range of antibacterial activity to both standard strains and environmental strains.
Similarly the aqueous extract of Peltigera polydactyla and the ethanol extract of the
Ramalina farinacea exhibited potent antibacterial activities (Karagoz et al. 2009).
The antimicrobial activity of the acetone, diethyl ether, and ethanol extracts of
the lichen Cetraria aculeata tested against different pathogenic bacteria and fungi
showed only with bacteria but not with fungi. In a related study, Roccella
belangeriana were extracted from different solvents like acetone, methanol, diethyl
ether, ethanol, ethyl acetate, petroleum ether, chloroform, and aqueous extracts and
tested against 12 bacterial strains. A maximum antibacterial activity was observed
from chloroform extracts against Enterococci sp., and minimum activity was
observed from ethyl acetate extract against Klebsiella pneumoniae, Enterococci
sp., Salmonella sp., and Shewanella sp. (Karthikaidevi et al. 2009). In addition,
antibacterial and antifungal activity of the acetone, methanol, and aqueous extracts
of the lichens Lecanora frustulosa and Parmeliopsis hyperopta have been screened
in vitro against the Bacillus mycoides, Bacillus subtilis, Staphylococcus aureus,
Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Aspergillus flavus,
Aspergillus fumigatus, Botrytis cinerea, Candida albicans, Fusarium oxysporum,
Mucor mucedo, Paecilomyces variotii, Penicillium purpurascens, Penicillium
verrucosum, and Trichoderma harzianum. Tested lichen species also showed strong
activity against both bacteria and fungi (Kosanić et al. 2010). This would perhaps
indicate that the lichens would be used in the treatment of various diseases.
According to Schmeda-Hirschmann et al. (2008), dichloromethane and metha-
nol extracts of Protousnea poeppigii had strong antifungal effects against the fungal
pathogens Microsporum gypseum, Trichophyton mentagrophytes, and T. rubrum.
The extracts were also active against the yeasts Candida albicans, C. tropicalis, and
Saccharomyces cerevisiae and the filamentous fungi Aspergillus niger, A. flavus,
and A. fumigatus but with much higher strength. In the same assay, extracts of
Usnea florida also showed strong antifungal properties. Methanol extracts of five
lichens from Antarctica (Caloplaca regalis, Caloplaca sp., Lecanora sp., Ramalina
terebrata, Stereocaulon alpinum) exhibited target-specific antibacterial activity,
especially strong against Gram-positive bacteria, compared to previously described
lichens (Paudel et al. 2008). Whiton and Lawrey (1982) reported that ascospore
germination of Sordaria fimicola was significantly inhibited by evernic and
vulpinic acids. Aqueous, ethanol, and ethyl acetate extracts of Alectoria sarmentosa
and Cladonia rangiferina were found to have moderate antifungal action against
different species of fungi, including human pathogens (Ranković and Mišić 2007),
3 Lichen Secondary Metabolites as Potential Antibiotic Agents 91
ethanol extracts showing the highest activity. Halama and Van Haluwin (2004)
reported that acetone extracts of Evernia prunastri and Hypogymnia physodes
showed a strong inhibitory effect on the growth of some plant pathogenic fungi,
i.e., Phytophthora infestans, Pythium ultimum, and Ustilago maydis.
Antimicrobial features of acetone, methanol, and aqueous extracts of lichens of
Cladonia furcata, Parmelia caperata, Parmelia pertusa, Hypogymnia physodes,
and Umbilicaria polyphylla were investigated by Ranković et al. (2009) by two
different methods at the same time. Testing of antimicrobial activities of extracts
from five species of lichens was performed by disk diffusion test in relation to
Gram-positive and Gram-negative bacteria and fungal organisms and through
determination of minimal inhibitory concentration (MIC) by broth tube dilution
method. They found that acetone and methanol extracts of all investigated lichens
in different concentrations manifested selective antibacterial and antifungal activ-
ity. That activity was more evident in relation to Gram-positive than Gram-negative
bacteria and fungal organisms. Acetone and methanol extracts of lichens Parmelia
pertusa, Hypogymnia physodes, and Umbilicaria polyphylla inhibited the growth of
all tested microorganisms, most of all of lichens Cladonia furcata and Parmelia
caperata. Although the methanol extracts were generally the most active against
the test organisms, the lowest MIC value was measured for acetone extract of
species Cladonia furcata 0.39 mg/ml in relation to bacterium Bacillus subtilis.
Aqueous extracts of investigated lichens were inactive against all tested organisms.
Santiago et al. (2010) examined antibacterial activity of 63 lichens collected
from different sites in Luzon Island, Philippines. Lichen crude extracts were then
tested against Gram-positive bacteria (Bacillus subtilis and Staphylococcus aureus)
and Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa) using
the paper disk diffusion assay. Their results showed that all 45 tested extracts
inhibited at least one of the test bacteria. However, only 38 extracts were found
to be very active (>19 mm zone of inhibition) against Gram-positive bacteria.
Similarly, Santos et al. (1964) observed that 30 of the 38 lichen extracts tested
inhibited at least one of the 12 test microorganisms, particularly the Gram-positive
test bacteria. Other studies also confirmed several lichens to be active against
Gram-positive microorganisms. For example, Saenz et al. (2006) found that four
species of lichens, namely, Ramalina canariensis, R. subfarinacea, Cladonia firma,
and Lecanora muralis, were most active against Gram-positive bacteria.
In vitro antifungal activity of acetone, methanol, and chloroform extracts of
Parmotrema tinctorum was investigated against ten plant pathogenic fungi, viz.,
Aspergillus niger, A. flavus, A. fumigatus, Alternaria alternata, Fusarium
oxysporum, F. solani, F. roseum, Ustilago sp., Albugo candida, and Penicillium
citrinum, with reference to commercially available synthetic antifungal drug keto-
conazole (positive control) using disk diffusion assay (Tiwari et al. 2011). Methanol
extract was most effective against all investigated fungi followed by acetone and
chloroform extract. Principal component analysis (PCA) concluded that though
ketoconazole was effective against five of the investigated fungi, the extracts of
Parmotrema tinctorum were more effective against the rest of the five broad-
spectrum plant pathogenic fungi (A. fumigatus, F. solani, F. roseum, P. citrinum,
and Ustilago spp.).
92 M. Kosanić and B. Ranković
against test bacteria. Balaji and Hariharan (2007) reported marked antimicrobial
efficacy of dichloromethane extract of P. praesorediosum. Kumar et al. (2010)
showed the antibacterial activity of methanol extract of P. pseudotinctorum. Sinha
and Biswas (2011) reported the antibacterial efficacy of solvent extracts of
P. reticulatum from Sikkim, India. Verma et al. (2011) found antibacterial efficacy
of solvent extracts of P. nilgherrensis and P. sanctiangelii collected from Karna-
taka, India. Chauhan and Abraham (2013) showed the inhibitory effect of methanol
extract of Parmotrema sp. against clinical isolates of bacteria. In addition, Javeria
et al. (2013) showed the inhibitory efficacy of solvent extracts of P. nilgherrense
against drug-resistant bacteria.
In the study described by Ranković et al. (2012), acetone lichen extracts
obtained from Usnea barbata showed a moderate antibacterial and antifungal
activity. It inhibited the microorganisms tested at concentrations from 0.125 to
12.5 mg/ml. The acetone extract from T. candida inhibited all the tested micro-
organisms, but at higher concentrations. In related research, Evernia prunastri and
Pseudoevernia furfuraceae lichens were screened for their antimicrobial effects by
Kosanić et al. (2013) who found varying antimicrobial success in the inhibition of
Gram-positive and Gram-negative bacteria and fungi, and Pseudoevernia
furfuraceae was found to be the most effective.
Kosanić et al. (2014a, b) extracted with acetone the three Cladonia species
(C. furcata, C. rangiferina, and C. pyxidata) in order to investigate their antimicrobial
effect. As test organisms in this study, Bacillus mycoides, B. subtilis, Staphylococcus
aureus, Escherichia coli, Klebsiella pneumonia, Aspergillus flavus, A. fumigatus,
Candida albicans, Penicillium purpurascens, and P. verrucosum were used. They
obtained results showing that extracts from C. furcata and C. rangiferina showed
similar antibacterial and antifungal activity. They inhibited the microorganisms
tested at concentrations from 0.78 to 25 mg/ml, while extracts from C. pyxidata
inhibited all the tested microorganisms, but at higher concentrations.
Lecanora muralis, Parmelia saxatilis, Parmeliopsis ambigua, Umbilicaria
crustulosa, and Umbilicaria polyphylla were tested for their antibacterial and
antifungal activity (Kosanić et al. 2014a, b). The antimicrobial activity was esti-
mated by determination of the minimal inhibitory concentration by the broth
microdilution method against six species of bacteria and ten species of fungi, and
it has been found that of the lichens tested, Umbilicaria polyphylla had the largest
antimicrobial activity with minimum inhibitory concentration values ranging from
0.78 to 1.56 mg/ml.
Such as the abovementioned, there are many studies on the antimicrobial activity of
crude lichen extracts. However, studies on antimicrobial activity of lichen com-
pounds are scarce and scattered. Lichens have been found to contain a variety of
secondary lichen substances with strong antimicrobial activity (Table 3.1).
94 M. Kosanić and B. Ranković
Table 3.1 List of lichen secondary metabolites used to evaluate antimicrobial activity
Lichen compounds References
Lecanoric acid Gomes et al. (2003), Ranković and Mišić (2008), Honda et al. (2010)
Atranorin Kumar and Müller (1999), Yilmaz et al. (2004), Turk et al. (2006),
Ranković et al. (2008, 2014), Kosanić et al. (2014a, b)
Zeorin Kosanić et al. (2010)
Gyrophoric acid Candan et al. (2006), Ranković et al. (2008)
Stenosporic acid Candan et al. (2006)
Protocetraric acid Tay et al. (2004), Ranković and Mišić (2008), Manojlović et al. (2012)
Fumarprotocetraric Yilmaz et al. (2004), Ranković and Mišić (2008), Kosanić et al. (2014a,
acid b)
Stictic acid Ranković and Mišić (2008)
Salazinic acid Candan et al. (2007), Manojlović et al. (2012)
Usnic acid Lauterwein et al. (1995), Perry et al. (1999), Yilmaz et al. (2003),
Ivanova et al. (2004), Tay et al. (2004), Ranković et al. (2008, 2012,
2014), Schmeda-Hirschmann et al. (2008), Ranković and Mišić (2009),
Paudel et al. (2010), Ramos and Silva (2010)
Vulpinic acid Whiton and Lawrey (1982), Lawrey (1986), Lauterwein et al. (1995)
Evernic acid Whiton and Lawrey (1982), Lawrey (1986), Halama and Van Haluwin
(2004), Kosanić et al. (2013)
Lobaric acid Ingolfsdottir et al. (1998), Piovano et al. (2002), Sundset et al. (2008)
Physodic acid Turk et al. (2006), Ranković et al. (2008, 2014), Kosanić et al. (2013)
Protolichesterinic Ingolfsdottir et al. (1998), Türk et al. (2003)
acid
Norstictic acid Tay et al. (2004), Honda et al. (2010), Ranković et al. (2014)
Ramalin Paudel et al. (2008, 2010)
Barbatic acid Martins et al. (2010)
Divaricatic acid Piovano et al. (2002), Kosanić et al. (2010)
Diffractaic acids Piovano et al. (2002), Honda et al. (2010)
Umbilicaric acid Buçukoglu et al. (2013)
Homosekikaic acid Sisodia et al. (2013)
Sekikaic acid Sisodia et al. (2013)
Parietin Manojlović et al. (2002, 2005)
Parietinic acid Manojlović et al. (2002)
Emodin Manojlović et al. (2002)
Fallacinal Manojlović et al. (2002)
Fallacinol Manojlović et al. (2002)
Isodivaricatic acid Schmeda-Hirschmann et al. (2008)
Divaricatinic acid Schmeda-Hirschmann et al. (2008)
Hirtusneanoside Renzaka and Sigler (2007)
Neuropogonines A, Ivanova et al. (2002)
B, and C
Hypostictic acid Honda et al. (2010)
Norstictic acid Honda et al. (2010)
Secalonic acid Honda et al. (2010)
Psoromic acid Tasdemir and Franzblau (2007)
Vulpic acid Tasdemir and Franzblau (2007)
Usimines A, B, and C Paudel et al. (2010)
3 Lichen Secondary Metabolites as Potential Antibiotic Agents 95
Literature sources mentioning data for numerous lichen substances with examined
antimicrobial activity are mentioned below.
Atranorin (from Physcia aipolia), fumarprotocetraric acid (from Cladonia
furcata), gyrophoric acid (from Umbilicaria polyphylla), lecanoric acid (from
Ochrolechia androgyna), physodic acid (from Hypogymnia physodes), proto-
cetraric acid (from Flavoparmelia caperata), stictic acid (from Parmelia
conspersa), and usnic acid (from Flavoparmelia caperata) showed relatively strong
antimicrobial effects against six bacteria and ten fungi, among which were human,
animal, and plant pathogens, mycotoxin producers, and food-spoilage organisms
(Ranković and Mišić 2008; Ranković et al. 2008). Usnic acid was found to be the
strongest antimicrobial agent (comparable to streptomycin) and physodic and
stictic acids the weakest.
The antifungal activity of ten depsidones and five depsides was evaluated, as
well as the antibacterial of these compounds and three additional depsides and one
diarylether; all of them were isolated from lichens growing in Chile (Piovano
et al. 2002). Obtained results showed, in general, negative activity against yeast
and filamentous fungi at concentrations of 250 mg/ml. Nevertheless, divaricatic and
diffractaic acids, and to a lesser degree lobaric acid, presented a moderate but
significant activity against Microsporum gypseum, Trichophyton mentagrophytes,
T. rubrum, and Epidermophyton floccosum, all of them being dermatophyte fungi
which cause skin infections. Regarding antibacterial activity, results indicated that
against Gram-negative bacteria, the 19 compounds are inactive. In contrast against
Gram-positive bacteria, a marked action can be observed for seven compounds.
Anthraquinones (parietin, parietinic acid, emodin, fallacinal, and fallacinol)
from Caloplaca schaereri were tested for antimicrobial activity using Bacillus
subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas fluorescens, Can-
dida albicans, Trichoderma harzianum, Aspergillus niger, and Penicillium
verrucosum (Manojlović et al. 2002). All the anthraquinones tested showed potent
antibacterial activity against B. subtilis, S. aureus, and P. fluorescens (MIC 20–
320 μg/ml), but only parietinic acid showed any activity against E. coli (MIC
160 μg/ml). Their effects are generally most potent on B. subtilis and P. fluorescens.
Fallacinol was most potent against S. aureus. Fallacinol was the most active
(potent) of the isolated compounds against all the fungi tested but was particularly
active against T. harzianum, A. niger, and P. verrucosum (MIC 10–40 μg/ml).
Potent antifungal effects on the fungi tested also showed parietinic acid (MIC 20–
80 μg/ml), while parietin had MIC values of 80, 40, and 20 μg/ml for C. albicans,
P. verrucosum, A. niger, and T. harzianum, respectively. Emodin showed MIC
values of 20–40 μg/ml for A. niger, T. harzianum, and P. verrucosum but was much
less effective against C. albicans (MIC 80 μg/ml).
According to Schmeda-Hirschmann et al. (2008), isodivaricatic acid,
divaricatinic acid, and usnic acid, the main lichen metabolites in Protousnea
poeppigii, displayed antifungal action against Microsporum gypseum,
Trichophyton mentagrophytes, and T. rubrum, usnic acid being less active.
Divaricatic acid and zeorin constituents of Lecanora frustulosa and Parmeliopsis
hyperopta have been screened in vitro against the Bacillus mycoides, Bacillus
96 M. Kosanić and B. Ranković
References
Abdullah ST, Hamid H, Ali M et al (2007) Two new terpenes from the lichen Parmelia perlata.
Ind J Chem 46B:173–176
Abo-Khatwa AN, al-Robai AA, al-Jawhari DA (1996) Lichen acids as uncouplers of oxidative
phosphorylation of mouse-liver mitochondria. Nat Toxins 4:96–102
Abraham EP, Chain E (1940) An enzyme from bacteria able to destroy penicillin. Nature 146:837
Bačkor M, Hudák J, Repčák M et al (1998) The influence of pH and lichen metabolites (vulpinic
acid and (+) usnic acid) on the growth of lichen photobiont Trebouxia irregularis. Lichenol-
ogist 30:577–582
Balaji P, Hariharan GN (2007) In vitro antimicrobial activity of Parmotrema praesorediosum
thallus extracts. Res J Bot 2:54–59
Behera BC, Verma N, Sonone A et al (2005) Antimicrobial activity of various solvent extracts of
lichen Usnea ghattensis. Agharkar Research Institute, Pune, India
Bouaid K, Vicente C (1998) Chlorophyll degradation effected by lichen substances. Ann Bot Fenn
35:71–74
Buçukoglu TZ, Albayrak S, Gökhan Halici M et al (2013) Antimicrobial and antioxidant activities
of extracts and lichen acids obtained from some Umbilicaria Species from Central Anatolia,
Turkey. J Food Process Preserv 37:1103–1110
100 M. Kosanić and B. Ranković
Burkholder PR, Evans AW (1945) Further studies on the antibiotic activity of lichens. Bull Torrey
Bot Club 72:157–164
Burkholder PR, Evans AW, McVeigh I et al (1944) Antibiotic activity of lichens. Proc Natl Acad
Sci USA 30:250–255
Byron F, Brehm S, Eric AJ (2003) Sensitization of Staphylococcus aureus and Escherichia coli to
antibiotics by the sesquiterpenoids. Antimicrob Agents Chemother 47:3357–3360
Candan M, Yilmaz M, Tay T et al (2006) Antimicrobial activity of extracts of the lichen
Xanthoparmelia pokornyi and its gyrophoric and stenosporic acid constituents. Z Naturforsch
61:319–323
Candan M, Yýlmaz M, Tay T et al (2007) Antimicrobial activity of extracts of the lichen Parmelia
sulcata and its salazinic acid constituent. Z Naturforsch 62:619–621
Chauhan R, Abraham J (2013) In vitro antimicrobial potential of the lichen Parmotrema sp. extracts
against various pathogens. Iran J Basic Med Sci 16:882–885
Cowan MM (1999) Plants products as antimicrobial agents. Clin Microbiol Rev 12:564–582
Culberson CF (1970) Supplement to chemical and botanical guide to lichen products. Bryologist
73:1–28
Dickert H, Machka K, Braveny I (1981) The uses and limitations of disc diffusion in the
antibiotic sensitivity testing of bacteria. Infection 9:18–24
Elo H, Matikainen J, Pelttari E (2007) Potent activity of the lichen antibiotic (+)-usnic acid against
clinical isolates of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus
aureus. Naturwissenschaften 94:465–468
Epand RF, Savage PB, Epand RM (2007) Bacterial lipid composition and the antimicrobial
efficacy of cationic steroid compounds. Biochim Biophys Acta 1768:2500–2509
Esimone CO, Adikwn MU (1999) Antimicrobial activity of the cytotoxicity of Ramalina farinacea.
Fitoterapia 7:428–431
Farkaš V (2003) Structure and biosynthesis of fungal cell walls: methodological approaches.
Folia Microbiol 48:469–478
Francolini I, Norris P, Piozzi A et al (2004) Usnic acid, a natural antimicrobial agent able to inhibit
bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother 48:4360–4365
Goel M, Dureja P, Rani A et al (2011) Isolation, characterization and antifungal activity of
major constituents of the Himalayan lichen Parmelia reticulate Tayl. J Agric Food Chem
59:2299–2307
Gomes AT, Honda NK, Roese FM et al (2002) Bioactive derivatives obtained from lecanoric acid,
a constituent of the lichen Parmotrema tinctorum (Nyl.). Hale (Parmeliaceae). Rev Bras Farm
12:74–75
Gomes AT, Smania A Jr, Seidel C et al (2003) Antibacterial activity of orsellinates. Braz J
Microbiol 34:194–196
Gulluce M, Aslan A, Sokmen M et al (2006) Screening the antioxidant and antimicrobial
properties of the lichens Parmelia saxatilis, Platismatia glauca, Ramalina pollinaria,
Ramalina polymorpha and Umbilicaria nylanderiana. Phytomedicine 13:515–521
Halama P, van Haluwin C (2004) Antifungal activity of lichen extracts and lichenic acids.
Biocontrol 49:95–107
Hauck M, Jurgens SR (2008) Usnic acid controls the acidity tolerance of lichens. Environ Pollut
156:115–122
Heijenoort J (2001) Formation of the glycan chains in the synthesis of bacterial peptidoglycan.
Glycobiology 11:25–36
Honda NK, Pavan FR, Coelho RG et al (2010) Antimycobacterial activity of lichen substances.
Phytomedicine 17:328–332
Ingolfsdottir K, Bloomfield SF, Hylands PJ (1985) In vitro evaluation of the antimicrobial activity
of lichen metabolites as potential preservatives. Antimicrob Agents Chemother 28:289–292
Ingolfsdottir K, Chung GAC, Skulason VG et al (1998) Antimycobacterial activity of lichen
metabolites in vitro. Eur J Pharm Sci 6:141–144
3 Lichen Secondary Metabolites as Potential Antibiotic Agents 101
Ranković B, Mišić M (2008) The antimicrobial activity of the lichen substances of the lichens
Cladonia furcata, Ochrolechia androgyna, Parmelia caperata and Parmelia conspresa.
Biotechnol Biotechnol Equip 22:1310–2818
Ranković B, Mišić M, Sukdolak S et al (2007a) Antimicrobial activity of the lichens Aspicilia
cinerea, Collema cristatum, Ochrolechia androgyna, Physcia aipolia and Physcia caesia. Ital J
Food Sci 19:461–469
Ranković B, Mišić M, Sukdolak S (2007b) Evaluation of antimicrobial activity of the lichens
Lasallia pustulata, Parmelia sulcata, Umbilicaria crustulosa and Umbilicaria cylindrical.
Microbiology 76:723–727
Ranković B, Mišić M, Sukdolak S (2008) The antimicrobial activity of substances derived from
the lichens Physcia aipolia, Umbilicaria polyphylla, Parmelia caperata and Hypogymnia
physodes. World J Microbiol Biotechnol 24:1239–1242
Ranković B, Mišić M, Sukdolak S (2009) Antimicrobial activity of extracts of the lichens
Cladonia furcata, Parmelia caperata, Parmelia pertusa, Hypogymnia physodes and
Umbilicaria polyphylla. Biologia 64:53–58
Ranković B, Ranković D, Kosanić M et al (2010) Antioxidant and antimicrobial properties of the
lichen Anaptychya ciliaris, Nephroma parile, Ochrolechia tartarea and Parmelia centrifuga.
Cent Eur J Biol 5:649–665
Ranković B, Kosanić M, Stanojković T (2011) Antioxidant, antimicrobial and anticancer activity
of the lichens Cladonia furcata, Lecanora atra and Lecanora muralis. BMC Complement
Altern Med. doi:10.1186/1472-6882-11-97
Ranković B, Kosanić M, Stanojković T et al (2012) Biological activities of Toninia candida and
Usnea barbata together with their norstictic acid and usnic acid constituents. Int J Mol Sci 13:
14707–14722
Ranković B, Kosanić M, Manojlović N et al (2014) Chemical composition of Hypogymnia
physodes lichen and biological activities of some its major metabolites. Med Chem Res 23:
408–416
Renzaka T, Sigler K (2007) Hirtusneanoside, an unsymmetrical dimeric tetrahydroxanthone from
the lichen Usnea hirta. J Nat Prod 70:1487–1491
Rundel PW (1978) The ecological role of secondary lichen substances. Biochem Syst Ecol 6:
157–170
Saenz MT, Garcia MD, Rowe JG (2006) Antimicrobial activity and phytochemical studies of
some lichens from south of Spain. Fitoterapia 77:156–159
Santiago KA, Borricano JN, Canal JN et al (2010) Antibacterial activities of fruticose lichens
collected from selected sites in Luzon Island, Philippines. Philipp Sci Lett 3:18–28
Santos PS, Lat B, Palo M (1964) The antibiotic activities of some Philippine lichens. Philipp J Sci
93:325–335
Sasidharan S, Chen Y, Saravanan D et al (2011) Extraction, isolation and characterization of
bioactive compounds from plants’ extracts. Afr J Tradit Complement Altern Med 8:1–10
Schmeda-Hirschmann G, Tapia A, Lima B et al (2008) A new antifungal and antiprotozoal depside
from the Andean lichen Protousnea poeppigii. Phytother Res 22:349–355
Sharma BC, Kalikotay S, Rai B (2012) Assessment of antimicrobial activity of extracts of
few common lichens of Darjeeling hills. Ind J Fund Appl Life Sci 2:120–126
Sheldon AT (2005) Antibiotic resistance: a survival strategy. Clin Lab Sci 18:170–180
Shrestha G, Raphael J, Leavitt SD et al (2014) In vitro evaluation of the antibacterial activity of
extracts from 34 species of North American lichens. Pharm Biol 27:1–5
Sinha SN, Biswas M (2011) Evaluation of antibacterial activity of some lichen from Ravangla,
Sikkim, India. Int J Pharm Bio Sci 2:B23–B28
Sisodia R, Geol M, Verma S et al (2013) Antibacterial and antioxidant activity of lichen species
Ramalina roesleri. Nat Prod Res 27:2235–2239
Srivastava P, Logesh AR, Upreti DK et al (2013) In-vitro evaluation of some Indian lichens against
human pathogenic bacteria. Mycosphere 4:734–743
104 M. Kosanić and B. Ranković